After six years of debate, the European Commission's attempts to harmonize biotechnology legislation still face opposition over the patenting of genes. Recent legal experience suggests that its efforts are unnecessary.
Article PDF
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Moss, G., Cohen, S. Time to abandon Brussels' bid on patents. Nature 372, 384 (1994). https://doi.org/10.1038/372384a0
Issue Date:
DOI: https://doi.org/10.1038/372384a0
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.